Protocol-Adaptable vs. Protocol-Specific Process Design
The most consequential decision in enrollment process design is whether to build protocol-specific processes or protocol-adaptable ones. A protocol-specific process is designed around the eligibility criteria, workflow requirements, and timeline of a single study. It may be operationally appropriate for that study, but it requires redesign from scratch when the next study activates. A protocol-adaptable process maintains a consistent operational architecture and documentation structure across studies while accepting protocol-specific eligibility criteria as configurable inputs at study activation.
For sites managing one study at a time and not planning to grow their trial portfolio, protocol-specific processes are not necessarily a problem. For sites managing two or more concurrent studies, or expecting to expand their protocol portfolio, protocol-adaptable design has dramatically lower total operational cost. Each new study adds eligibility criteria configuration to an existing framework rather than triggering a full process development cycle. Activation ramp-up time drops, SOP consistency improves across the portfolio, and cross-study KPI comparison becomes meaningful.
The discipline required to maintain protocol-adaptable design is real and worth acknowledging. When a new protocol arrives with a long list of complex eligibility criteria, the temptation is to build a fully custom workflow rather than adapting the shared framework. Resisting this temptation — mapping each protocol's criteria to the shared checklist structure rather than creating a new one — is what keeps infrastructure scalable. Sites that allow protocol-specific customization to accumulate across studies find themselves managing a portfolio of incompatible processes rather than a single adaptable infrastructure.
A useful planning heuristic: if a site expects to activate more than two studies in any 12-month period, protocol-adaptable process design should be a non-negotiable design requirement from the beginning. If study volume is unlikely to grow beyond a single protocol, the investment in protocol-adaptable architecture is still worthwhile given the compounding operational benefits over multiple study cycles.